{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:10:59Z","timestamp":1707523859855},"reference-count":36,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,12]]},"DOI":"10.7759\/cureus.30229","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T17:48:17Z","timestamp":1665596897000},"source":"Crossref","is-referenced-by-count":2,"title":["Intravenous Carbetocin Versus Rectal Misoprostol for the Active Management of the Third Stage of Labor: A Systematic Review and Meta-Analysis of Randomized Controlled Trials"],"prefix":"10.7759","author":[{"given":"Ebraheem","family":"Albazee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanaa","family":"Alrashidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roa","family":"Laqwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shouq R","family":"Elmokid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wessam A","family":"Alghamdi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hend","family":"Almahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muneera","family":"AlGhareeb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nora","family":"Alfertaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danah I","family":"Alkandari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatma","family":"AlDabbous","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaber","family":"Alkanderi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haifa","family":"Al-Jundy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed","family":"Abu-Zaid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osama","family":"Alomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00838-7","article-title":"Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group","volume":"387","author":"Alkema L","year":"2016","unstructured":"Alkema L, Chou D, Hogan D, et al.. Global, regional, and national levels and trends in maternal mortality between 1990 and 2015, with scenario-based projections to 2030: a systematic analysis by the UN Maternal Mortality Estimation Inter-Agency Group. Lancet. 2016, 387:462-74. 10.1016\/S0140-6736(15)00838-7","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(14)70227-x","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say L","year":"2014","unstructured":"Say L, Chou D, Gemmill A, et al.. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014, 2:323-33. 10.1016\/s2214-109x(14)70227-x","journal-title":"Lancet Glob Health"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011689.pub3","article-title":"Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis","volume":"12","author":"Gallos ID","year":"2018","unstructured":"Gallos ID, Papadopoulou A, Man R, et al.. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018, 12:CD011689. 10.1002\/14651858.CD011689.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e328014a860","article-title":"Near miss audit in obstetrics","volume":"19","author":"Penney G","year":"2007","unstructured":"Penney G, Brace V. Near miss audit in obstetrics. Curr Opin Obstet Gynecol. 2007, 19:145-50. 10.1097\/GCO.0b013e328014a860","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0041114","article-title":"Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis","volume":"7","author":"Calvert C","year":"2012","unstructured":"Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS One. 2012, 7:e41114. 10.1371\/journal.pone.0041114","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000139","article-title":"Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management","volume":"2020","author":"McLintock C","year":"2020","unstructured":"McLintock C. Prevention and treatment of postpartum hemorrhage: focus on hematological aspects of management. Hematology Am Soc Hematol Educ Program. 2020, 2020:542-6. 10.1182\/hematology.2020000139","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009336.pub2","article-title":"Advance misoprostol distribution for preventing and treating postpartum haemorrhage","author":"Oladapo OT","year":"2012","unstructured":"Oladapo OT, Fawole B, Blum J, Abalos E. Advance misoprostol distribution for preventing and treating postpartum haemorrhage. Cochrane Database Syst Rev. 2012, CD009336. 10.1002\/14651858.CD009336.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.12361","article-title":"Preventing postpartum haemorrhage: active management of the third stage of labour","volume":"22","author":"de Castro Parreira MV","year":"2013","unstructured":"de Castro Parreira MV, Gomes NC. Preventing postpartum haemorrhage: active management of the third stage of labour. J Clin Nurs. 2013, 22:3372-87. 10.1111\/jocn.12361","journal-title":"J Clin Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02807.x","article-title":"Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial","volume":"118","author":"Mobeen N","year":"2011","unstructured":"Mobeen N, Durocher J, Zuberi N, et al.. Administration of misoprostol by trained traditional birth attendants to prevent postpartum haemorrhage in homebirths in Pakistan: a randomised placebo-controlled trial. BJOG. 2011, 118:353-61. 10.1111\/j.1471-0528.2010.02807.x","journal-title":"BJOG"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003249.pub3","article-title":"Treatment for primary postpartum haemorrhage","author":"Mousa HA","year":"2014","unstructured":"Mousa HA, Blum J, Abou El Senoun G, Shakur H, Alfirevic Z. Treatment for primary postpartum haemorrhage. Cochrane Database Syst Rev. 2014, CD003249. 10.1002\/14651858.CD003249.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2008.06.010","article-title":"Oxytocin: new perspectives on an old drug","volume":"200","author":"Clark SL","year":"2009","unstructured":"Clark SL, Simpson KR, Knox GE, Garite TJ. Oxytocin: new perspectives on an old drug. Am J Obstet Gynecol. 2009, 200:35.e1-6. 10.1016\/j.ajog.2008.06.010","journal-title":"Am J Obstet Gynecol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2022.102358","article-title":"Efficacy of oxytocics on reducing intraoperative blood loss during abdominal myomectomy: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"51","author":"Albazee E","year":"2022","unstructured":"Albazee E, Sayad R, Elrashedy AA, Samy Z, Faraag E, Baradwan S, Samy A. Efficacy of oxytocics on reducing intraoperative blood loss during abdominal myomectomy: a systematic review and meta-analysis of randomized placebo-controlled trials. J Gynecol Obstet Hum Reprod. 2022, 51:102358. 10.1016\/j.jogoh.2022.102358","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1329184","article-title":"Dose and duration of oxytocin to prevent postpartum hemorrhage: a review","volume":"30","author":"Roach MK","year":"2013","unstructured":"Roach MK, Abramovici A, Tita AT. Dose and duration of oxytocin to prevent postpartum hemorrhage: a review. Am J Perinatol. 2013, 30:523-8. 10.1055\/s-0032-1329184","journal-title":"Am J Perinatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2006.12.005","article-title":"Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings","volume":"97","author":"Bradley SE","year":"2007","unstructured":"Bradley SE, Prata N, Young-Lin N, Bishai DM. Cost-effectiveness of misoprostol to control postpartum hemorrhage in low-resource settings. Int J Gynaecol Obstet. 2007, 97:52-6. 10.1016\/j.ijgo.2006.12.005","journal-title":"Int J Gynaecol Obstet"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000494.pub4","article-title":"Prostaglandins for preventing postpartum haemorrhage","author":"Tun\u00e7alp \u00d6","year":"2012","unstructured":"Tun\u00e7alp \u00d6, Hofmeyr GJ, G\u00fclmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012, CD000494. 10.1002\/14651858.CD000494.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005457.pub4","article-title":"Carbetocin for preventing postpartum haemorrhage","author":"Su LL","year":"2012","unstructured":"Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012, CD005457. 10.1002\/14651858.CD005457.pub4","journal-title":"Cochrane Database Syst Rev"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijoa.2016.10.003","article-title":"The role of carbetocin in the prevention and management of postpartum haemorrhage","volume":"28","author":"Meshykhi LS","year":"2016","unstructured":"Meshykhi LS, Nel MR, Lucas DN. The role of carbetocin in the prevention and management of postpartum haemorrhage. Int J Obstet Anesth. 2016, 28:61-9. 10.1016\/j.ijoa.2016.10.003","journal-title":"Int J Obstet Anesth"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s13224-020-01338-0","article-title":"Randomised controlled trial of sublingual and rectal misoprostol in the prevention of primary postpartum haemorrhage in a resource-limited community","volume":"70","author":"Awoleke JO","year":"2020","unstructured":"Awoleke JO, Adeyanju BT, Adeniyi A, Aduloju OP, Olofinbiyi BA. Randomised controlled trial of sublingual and rectal misoprostol in the prevention of primary postpartum haemorrhage in a resource-limited community. J Obstet Gynaecol India. 2020, 70:462-70. 10.1007\/s13224-020-01338-0","journal-title":"J Obstet Gynaecol India"},{"key":"ref19","article-title":"Cochrane Handbook for Systematic Reviews of Interventions","year":"2011","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (ed) (ed). Cochrane, London, England; 2011."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-021-01626-4","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"10","author":"Page MJ","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, et al.. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Syst Rev. 2021, 10:89. 10.1186\/s13643-021-01626-4","journal-title":"Syst Rev"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne JA","year":"2019","unstructured":"Sterne JA, Savovi\u0107 J, Page MJ, et al.. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019, 366:l4898. 10.1136\/bmj.l4898","journal-title":"BMJ"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger M","year":"1997","unstructured":"Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315:629-34. 10.1136\/bmj.315.7109.629","journal-title":"BMJ"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins JP","year":"2003","unstructured":"Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003, 327:557-60. 10.1136\/bmj.327.7414.557","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.21608\/AMJ.2020.120624","article-title":"The effect of carbetocin compared to rectal misoprostol in the management of blood loss during the third stage of vaginal delivery in low risk patients for postpartum hemorrhage","volume":"49","author":"Abd El-Wahab AS","year":"2020","unstructured":"Abd El-Wahab AS, Ahmed AAK, Marai AAE. The effect of carbetocin compared to rectal misoprostol in the management of blood loss during the third stage of vaginal delivery in low risk patients for postpartum hemorrhage. Al-Azhar Med J. 2020, 49:1673-82. 10.21608\/AMJ.2020.120624","journal-title":"Al-Azhar Med J"},{"key":"ref25","article-title":"Carbetocin versus rectal misoprostol to decrease blood loss in vaginal delivery in high risk patients for postpartum hemorrhage","volume":"3","author":"Hetiba YA","year":"2021","unstructured":"Hetiba YA, Mahmoud MS, Oun AEM. Carbetocin versus rectal misoprostol to decrease blood loss in vaginal delivery in high risk patients for postpartum hemorrhage. IJMA. 2021, 3:1923-9.","journal-title":"IJMA"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.13056","article-title":"Carbetocin versus rectal misoprostol for management of third stage of labor among women with low risk of postpartum hemorrhage","volume":"148","author":"Maged AM","year":"2020","unstructured":"Maged AM, Waly M, Fahmy RM, et al.. Carbetocin versus rectal misoprostol for management of third stage of labor among women with low risk of postpartum hemorrhage. Int J Gynaecol Obstet. 2020, 148:238-42. 10.1002\/ijgo.13056","journal-title":"Int J Gynaecol Obstet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-018-0832-4","article-title":"The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review","volume":"7","author":"Abd El Aziz MA","year":"2018","unstructured":"Abd El Aziz MA, Iraqi A, Abedi P, Jahanfar S. The effect of carbetocin compared to misoprostol in management of the third stage of labor and prevention of postpartum hemorrhage: a systematic review. Syst Rev. 2018, 7:170. 10.1186\/s13643-018-0832-4","journal-title":"Syst Rev"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.18203\/2320-1770.ijrcog20180161","article-title":"Adjunctive sublingual misoprostol for secondary prevention of post-partum hemorrhage during cesarean delivery: double blind placebo randomized controlled trial","volume":"7","author":"Sallam HF","year":"2018","unstructured":"Sallam HF, Shady NW. Adjunctive sublingual misoprostol for secondary prevention of post-partum hemorrhage during cesarean delivery: double blind placebo randomized controlled trial. Int J Reprod Contracept Obstet Gynecol. 2018, 7:496-502.","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-0528.2010.02585.x","article-title":"Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial","volume":"117","author":"Attilakos G","year":"2010","unstructured":"Attilakos G, Psaroudakis D, Ash J, et al.. Carbetocin versus oxytocin for the prevention of postpartum haemorrhage following caesarean section: the results of a double-blind randomised trial. BJOG. 2010, 117:929-36. 10.1111\/j.1471-0528.2010.02585.x","journal-title":"BJOG"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.apme.2017.02.008","article-title":"Prevention of postpartum haemorrhage in patients with severe preeclampsia using carbetocin versus misoprostol","volume":"14","author":"Ibrahim KA","year":"2017","unstructured":"Ibrahim KA, Saad AS. Prevention of postpartum haemorrhage in patients with severe preeclampsia using carbetocin versus misoprostol. Apollo Med. 2017, 14:117-22. 10.1016\/j.apme.2017.02.008","journal-title":"Apollo Med"},{"key":"ref31","article-title":"Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage","volume":"7","author":"Larciprete G","year":"2013","unstructured":"Larciprete G, Montagnoli C, Frigo M, et al.. Carbetocin versus oxytocin in caesarean section with high risk of post-partum haemorrhage. J Prenat Med. 2013, 7:12-8.","journal-title":"J Prenat Med"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/ijgo.12836","article-title":"A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage","volume":"146","author":"Lawrie TA","year":"2019","unstructured":"Lawrie TA, Rogozi\u0144ska E, Sobiesuo P, Vogel JP, Ternent L, Oladapo OT. A systematic review of the cost-effectiveness of uterotonic agents for the prevention of postpartum hemorrhage. Int J Gynaecol Obstet. 2019, 146:56-64. 10.1002\/ijgo.12836","journal-title":"Int J Gynaecol Obstet"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/13696998.2022.2027669","article-title":"Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom","volume":"25","author":"Matthijsse S","year":"2022","unstructured":"Matthijsse S, Andersson FL, Gargano M, Yip Sonderegger YL. Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom. J Med Econ. 2022, 25:129-37. 10.1080\/13696998.2022.2027669","journal-title":"J Med Econ"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2015.10.015","article-title":"Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal","volume":"133","author":"Vlassoff M","year":"2016","unstructured":"Vlassoff M, Diallo A, Philbin J, Kost K, Bankole A. Cost-effectiveness of two interventions for the prevention of postpartum hemorrhage in Senegal. Int J Gynaecol Obstet. 2016, 133:307-11. 10.1016\/j.ijgo.2015.10.015","journal-title":"Int J Gynaecol Obstet"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2021.08.060","article-title":"Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents","volume":"226","author":"Jaffer D","year":"2022","unstructured":"Jaffer D, Singh PM, Aslam A, Cahill AG, Palanisamy A, Monks DT. Preventing postpartum hemorrhage after cesarean delivery: a network meta-analysis of available pharmacologic agents. Am J Obstet Gynecol. 2022, 226:347-65. 10.1016\/j.ajog.2021.08.060","journal-title":"Am J Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.3310\/hta23090","article-title":"Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis","volume":"23","author":"Gallos I","year":"2019","unstructured":"Gallos I, Williams H, Price M, et al.. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis. Health Technol Assess. 2019, 23:1-356. 10.3310\/hta23090","journal-title":"Health Technol Assess"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/118933-intravenous-carbetocin-versus-rectal-misoprostol-for-the-active-management-of-the-third-stage-of-labor-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:53Z","timestamp":1707508013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/118933-intravenous-carbetocin-versus-rectal-misoprostol-for-the-active-management-of-the-third-stage-of-labor-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":36,"URL":"https:\/\/doi.org\/10.7759\/cureus.30229","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,12]]}}}